193 related articles for article (PubMed ID: 34447304)
1. Dose Dependent Antimicrobial Cellular Cytotoxicity-Implications for
Copaescu A; Choshi P; Pedretti S; Mouhtouris E; Peter J; Trubiano JA
Front Pharmacol; 2021; 12():640012. PubMed ID: 34447304
[No Abstract] [Full Text] [Related]
2. The Role of In Vivo and Ex Vivo Diagnostic Tools in Severe Delayed Immune-Mediated Adverse Antibiotic Drug Reactions.
Copaescu A; Mouhtouris E; Vogrin S; James F; Chua KYL; Holmes NE; Douglas A; Slavin MA; Cleland H; Zubrinich C; Aung AK; Goh MSY; Phillips EJ; Trubiano JA;
J Allergy Clin Immunol Pract; 2021 May; 9(5):2010-2015.e4. PubMed ID: 33453452
[TBL] [Abstract][Full Text] [Related]
3. The Combined Utility of Ex Vivo IFN-γ Release Enzyme-Linked ImmunoSpot Assay and In Vivo Skin Testing in Patients with Antibiotic-Associated Severe Cutaneous Adverse Reactions.
Trubiano JA; Strautins K; Redwood AJ; Pavlos R; Konvinse KC; Aung AK; Slavin MA; Thursky KA; Grayson ML; Phillips EJ
J Allergy Clin Immunol Pract; 2018; 6(4):1287-1296.e1. PubMed ID: 29100867
[TBL] [Abstract][Full Text] [Related]
4. Novel interferon-γ enzyme-linked immunoSpot assay using activated cells for identifying hypersensitivity-inducing drug culprits.
Kato K; Kawase A; Azukizawa H; Hanafusa T; Nakagawa Y; Murota H; Sakaguchi S; Asada H; Katayama I
J Dermatol Sci; 2017 Jun; 86(3):222-229. PubMed ID: 28330775
[TBL] [Abstract][Full Text] [Related]
5. IFN-γ ELISpot in Severe Cutaneous Adverse Reactions to First-Line Antituberculosis Drugs in an HIV Endemic Setting.
Porter M; Choshi P; Pedretti S; Chimbetete T; Smith R; Meintjes G; Phillips E; Lehloenya R; Peter J
J Invest Dermatol; 2022 Nov; 142(11):2920-2928.e5. PubMed ID: 35659939
[TBL] [Abstract][Full Text] [Related]
6. Blister fluid as a cellular input for
Awad A; Mouhtouris E; Nguyen-Robertson CV; Holmes N; Chua KYL; Copaescu A; James F; Goh MS; Aung AK; Godfrey DI; Philips EJ; Gibson A; Almeida CF; Trubiano JA;
J Allergy Clin Immunol Glob; 2022 Feb; 1(1):16-21. PubMed ID: 37780076
[TBL] [Abstract][Full Text] [Related]
7. Impact of delayed PBMC processing on functional and genomic assays.
Yi PC; Zhuo L; Lin J; Chang C; Goddard A; Yoon OK
J Immunol Methods; 2023 Aug; 519():113514. PubMed ID: 37353001
[TBL] [Abstract][Full Text] [Related]
8. Porcine antigen-specific IFN-γ ELISpot as a potentially valuable tool for monitoring cellular immune responses in pig-to-non-human primate islet xenotransplantation.
Kim HJ; Yoon IH; Min BH; Kim YH; Shin JS; Kim JM; Kim JS; Nam HY; Lee WW; Park CG
Xenotransplantation; 2016 Jul; 23(4):310-9. PubMed ID: 27464486
[TBL] [Abstract][Full Text] [Related]
9. An adaptation of recombinant vaccinia-based ELISPOT and intracellular cytokine staining for a comparative measurement of cellular immune responses in HIV-1 and HIV-2 infections in West Africa.
Eshofonie A; van der Loeff MS; Whittle H; Jaye A
Clin Exp Immunol; 2006 Dec; 146(3):471-8. PubMed ID: 17100767
[TBL] [Abstract][Full Text] [Related]
10. In vitro test to confirm diagnosis of allopurinol-induced severe cutaneous adverse reactions.
Klaewsongkram J; Thantiworasit P; Suthumchai N; Rerknimitr P; Sukasem C; Tuchinda P; Chularojanamontri L; Srinoulprasert Y; Rerkpattanapipat T; Chanprapaph K; Disphanurat W; Chakkavittumrong P; Tovanabutra N; Srisuttiyakorn C
Br J Dermatol; 2016 Nov; 175(5):994-1002. PubMed ID: 27106261
[TBL] [Abstract][Full Text] [Related]
11. Ex-vivo whole blood secretion of interferon (IFN)-γ and IFN-γ-inducible protein-10 measured by enzyme-linked immunosorbent assay are as sensitive as IFN-γ enzyme-linked immunospot for the detection of gluten-reactive T cells in human leucocyte antigen (HLA)-DQ2·5(+) -associated coeliac disease.
Ontiveros N; Tye-Din JA; Hardy MY; Anderson RP
Clin Exp Immunol; 2014 Feb; 175(2):305-15. PubMed ID: 24192268
[TBL] [Abstract][Full Text] [Related]
12. Proficiency tests to evaluate the impact on assay outcomes of harmonized influenza-specific Intracellular Cytokine Staining (ICS) and IFN-ɣ Enzyme-Linked ImmunoSpot (ELISpot) protocols.
Waerlop G; Leroux-Roels G; Pagnon A; Begue S; Salaun B; Janssens M; Medaglini D; Pettini E; Montomoli E; Gianchecchi E; Lambe T; Godfrey L; Bull M; Bellamy D; Amdam H; Bredholt G; Cox RJ; Clement F
J Immunol Methods; 2023 Dec; 523():113584. PubMed ID: 37918618
[TBL] [Abstract][Full Text] [Related]
13. The Role of
Klaewsongkram J; Buranapraditkun S; Thantiworasit P; Rerknimitr P; Tuchinda P; Chularojanamontri L; Rerkpattanapipat T; Chanprapaph K; Disphanurat W; Chakkavittumrong P; Tovanabutra N; Srisuttiyakorn C; Srinoulprasert Y; Sukasem C; Chongpison Y
Allergy Asthma Immunol Res; 2021 Nov; 13(6):896-907. PubMed ID: 34734507
[TBL] [Abstract][Full Text] [Related]
14. IFN-γ ELISpot-enabled machine learning for culprit drug identification in nonimmediate drug hypersensitivity.
Chongpison Y; Sriswasdi S; Buranapraditkun S; Thantiworasit P; Rerknimitr P; Mongkolpathumrat P; Chularojanamontri L; Srinoulprasert Y; Rerkpattanapipat T; Chanprapaph K; Disphanurat W; Chakkavittumrong P; Tovanabutra N; Srisuttiyakorn C; Sukasem C; Tuchinda P; Pongcharoen P; Klaewsongkram J
J Allergy Clin Immunol; 2024 Jan; 153(1):193-202. PubMed ID: 37678574
[TBL] [Abstract][Full Text] [Related]
15. The Granzyme B ELISPOT assay: an alternative to the 51Cr-release assay for monitoring cell-mediated cytotoxicity.
Shafer-Weaver K; Sayers T; Strobl S; Derby E; Ulderich T; Baseler M; Malyguine A
J Transl Med; 2003 Dec; 1(1):14. PubMed ID: 14697097
[TBL] [Abstract][Full Text] [Related]
16. Expression of the chemokine MIG is a sensitive and predictive marker for antigen-specific, genetically restricted IFN-gamma production and IFN-gamma-secreting cells.
Brice GT; Graber NL; Hoffman SL; Doolan DL
J Immunol Methods; 2001 Nov; 257(1-2):55-69. PubMed ID: 11687239
[TBL] [Abstract][Full Text] [Related]
17. In-vivo and ex-vivo tests for culprit drugs identification in severe cutaneous adverse drugs reactions.
Sittiwattanawong P; Kantikosum K; Charoenchaipiyakul K; Pootongkam S; Asawanonda P; Kerr SJ; Thantiworasit P; Sodsai P; Hirankarn N; Klaewsongkram J; Rerknimitr P
J Dermatol; 2024 Apr; ():. PubMed ID: 38605448
[TBL] [Abstract][Full Text] [Related]
18. The measurement of drug-induced interferon γ-releasing cells and lymphocyte proliferation in severe cutaneous adverse reactions.
Suthumchai N; Srinoulprasert Y; Thantiworasit P; Rerknimitr P; Tuchinda P; Chularojanamontri L; Rerkpattanapipat T; Chanprapaph K; Disphanurat W; Chakkavittumrong P; Tovanabutra N; Srisuttiyakorn C; Sukasem C; Klaewsongkram J;
J Eur Acad Dermatol Venereol; 2018 Jun; 32(6):992-998. PubMed ID: 29478292
[TBL] [Abstract][Full Text] [Related]
19. The Ex Vivo IFN-γ Enzyme-Linked Immunospot (ELISpot) Assay.
Sedegah M
Methods Mol Biol; 2015; 1325():197-205. PubMed ID: 26450390
[TBL] [Abstract][Full Text] [Related]
20. Identification of the association between HBcAg-specific T cell and viral control in chronic HBV infection using a cultured ELISPOT assay.
Chen C; Jiang X; Liu X; Guo L; Wang W; Gu S; Wen C; Yi X; Tang L; Li Y
J Leukoc Biol; 2021 Feb; 109(2):455-465. PubMed ID: 32620046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
